SARS-COV-2 IgG specific antibodies persistence in recovered COVID-19 individuals and its association with severity and time of illness
In order to accurately interpret the immune response to COVID-19, it is critical to know how long serum antibodies to COVID-2 persist. This study aimed to describe the serum IgG responses to SARS-CoV-2 in patients with mild, moderate, and severe COVID-19 infection in Birjand, South Khorasan province...
Main Authors: | Abdol Sattar Pagheh, Arash Ziaee, Khadijeh Abrari Romenjan, Fatemeh Rezaei, Babak Bahman, Effat Alamzadeh, Samira Elhamirad, Masood Ziaee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | New Microbes and New Infections |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S205229752300015X |
Similar Items
-
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients
by: Li Yang, et al.
Published: (2021-12-01) -
Factors associated with IgG levels in adults with IgG subclass deficiency
by: James C. Barton, et al.
Published: (2021-08-01) -
Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01) -
Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis
by: Jiansheng Huang, et al.
Published: (2024-07-01) -
Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways
by: Gina-Maria Lilienthal, et al.
Published: (2018-05-01)